Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

33.7K
Overview
33.7K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

182
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
182
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

147
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
147
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

171
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
171
Cross-reactivity00:42

Cross-reactivity

33.9K
Overview
33.9K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Fish-induced food protein-induced enterocolitis syndrome (FPIES) in children: Geography matters and tolerance is more than a challenge date.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Longitudinal Prescribing Patterns of Mammalian Allergen Immunotherapy Across the U.S. Military Healthcare System from 2005-2024.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Stability of epinephrine nasal spray under room temperature, freeze-thaw, and extreme temperature conditions.

The journal of allergy and clinical immunology. In practice·2026
Same author

American College of Allergy, Asthma and Immunology (ACAAI)/American Academy of Pediatrics (AAP) symposium-What was served in the past year: Food allergy nontreatment.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Burnout in the allergy nursing workforce in the United States.

Frontiers in health services·2026
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

14.1K

Venom Anaphylaxis.

Jeremy C McMurray1, Theresa A Bingemann2, David B K Golden3

  • 1Department of Allergy and Immunology, Walter Reed National Military Medical Center, 4954 North Palmer Road, Bethesda, MD 20889, USA; Department of Pediatrics, Uniformed Services University, 4954 North Palmer Road, Bethesda, MD 20889 USA.

Immunology and Allergy Clinics of North America
|April 3, 2026
PubMed
Summary
This summary is machine-generated.

Stinging insect venom allergies can cause severe reactions like anaphylaxis. Venom immunotherapy is highly effective, with most patients safely discontinuing treatment after five years.

Keywords:
AnaphylaxisEpidemiologyHymenopteraStinging insect allergyVenom anaphylaxis

More Related Videos

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.9K
Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

4.6K

Related Experiment Videos

Last Updated: Apr 5, 2026

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

14.1K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.9K
Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

4.6K

Area of Science:

  • Immunology
  • Allergology
  • Toxicology

Background:

  • Allergies to stinging insect venoms (bees, wasps, ants) can lead to significant local or systemic reactions, including life-threatening anaphylaxis.
  • Accurate diagnosis and effective management are crucial for patient safety and quality of life.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for stinging insect venom allergies.
  • To discuss the long-term management and potential discontinuation of venom immunotherapy.

Main Methods:

  • Diagnostic evaluation involves skin testing and/or serum venom-specific IgE testing.
  • Basal serum tryptase levels are measured to detect underlying mast cell disorders.
  • Treatment recommendations include epinephrine prescription and venom immunotherapy.

Main Results:

  • Venom immunotherapy demonstrates high efficacy, preventing allergic reactions in up to 98% of patients.
  • Most patients can safely discontinue venom immunotherapy after a 5-year course.
  • High-risk individuals may require indefinite continuation of venom immunotherapy.

Conclusions:

  • Effective diagnostic tools and treatments, including venom immunotherapy, are available for stinging insect venom allergies.
  • Further research is necessary to enhance diagnostic test predictability and treatment safety and efficacy.